(Q36861572)

16 August 2017

1 reference

title

Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use. (English)

1 reference

16 August 2017

1 reference

0 references

Amar Safdar

1

1 reference

16 August 2017

Manon M J Cox

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

Expert Opinion on Investigational Drugs

16 August 2017

published in

1 reference

16 August 2017

volume

16

1 reference

16 August 2017

issue

7

1 reference

16 August 2017

page(s)

927-934

1 reference

Prevention and treatment of influenza

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Infectious morbidity in critically ill patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Influenza, influenza virus vaccine, and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Current research on influenza and other respiratory viruses: II international symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Summary of Clinical Trials of Influenza Virus Vaccines in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Production of a novel influenza vaccine using insect cells: protection against drifted strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Recombinant neuraminidase vaccine protects against lethal influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Protection of mice with recombinant influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Influenza virus M2 protein has ion channel activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Antibody response to the M2 protein of influenza A virus expressed in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

How pH opens a H+ channel: the gating mechanism of influenza A M2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

The M2 proton channels of influenza A and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Modified M2 proteins produce heterotypic immunity against influenza A virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Avian influenza--a challenge to global health care structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Confronting the avian influenza threat: vaccine development for a potential pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.7.927

10.1517/13543784.16.7.927

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference